In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CombiMatrix gains $2.2m US funding:

This article was originally published in Clinica

Executive Summary

The US Department of Defense (DoD) has awarded a one-year, $2.2m contract to CombiMatrix to fund the further development of its microarrays for a multipathogen- and chemical-detection system, using its "on chip" electrochemical detection process. The Newport Beach, California company has demonstrated that its products can simultaneously detect toxins, viruses and bacteria using its semiconductor-based microarrays, under previously DoD-funded research programmes. These systems are currently in use at several military and government laboratories as well as civilian installations.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts